These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of Parenteral Opioid Dosing in Adult Sickle Cell Disease Patients With Vaso-occlusive Crisis. Shah SP; Twilla JD; Kemp L; Phelps GL; Reaves A J Pain Palliat Care Pharmacother; 2018 Dec; 32(4):201-207. PubMed ID: 30896312 [TBL] [Abstract][Full Text] [Related]
3. Hospitalist management of vaso-occlusive pain crisis in patients with sickle cell disease using a pathway of care. Allen Liles E; Kirsch J; Gilchrist M; Adem M Hosp Pract (1995); 2014 Apr; 42(2):70-6. PubMed ID: 24769786 [TBL] [Abstract][Full Text] [Related]
4. Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial. van Beers EJ; van Tuijn CF; Nieuwkerk PT; Friederich PW; Vranken JH; Biemond BJ Am J Hematol; 2007 Nov; 82(11):955-60. PubMed ID: 17617790 [TBL] [Abstract][Full Text] [Related]
6. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome. Buchanan ID; Woodward M; Reed GW Pediatr Blood Cancer; 2005 Oct; 45(5):716-24. PubMed ID: 15926170 [TBL] [Abstract][Full Text] [Related]
7. IMPROVE trial: a randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studies. Dampier CD; Smith WR; Wager CG; Kim HY; Bell MC; Miller ST; Weiner DL; Minniti CP; Krishnamurti L; Ataga KI; Eckman JR; Hsu LL; McClish D; McKinlay SM; Molokie R; Osunkwo I; Smith-Whitley K; Telen MJ; Clin Trials; 2013 Apr; 10(2):319-31. PubMed ID: 23539110 [TBL] [Abstract][Full Text] [Related]
8. Demand-only patient-controlled analgesia for treatment of acute vaso-occlusive pain in sickle cell disease. Carullo V; Morrone K; Weiss M; Choi J; Gao Q; Pisharoty S; Moody K; Manwani D Pediatr Blood Cancer; 2022 Aug; 69(8):e29665. PubMed ID: 35294090 [TBL] [Abstract][Full Text] [Related]
9. A comparison of two regimens of patient-controlled analgesia for children with sickle cell disease. Trentadue NO; Kachoyeanos MK; Lea G J Pediatr Nurs; 1998 Feb; 13(1):15-9. PubMed ID: 9503762 [TBL] [Abstract][Full Text] [Related]
10. Patient-controlled analgesia compared with interval analgesic dosing for reducing complications in blunt thoracic trauma: a retrospective cohort study. Asha SE; Curtis KA; Taylor C; Kwok A Emerg Med J; 2013 Dec; 30(12):1024-8. PubMed ID: 23221457 [TBL] [Abstract][Full Text] [Related]
11. An innovative short-stay health care model for treatment of uncomplicated vaso-occlusive crisis in adult sickle cell disease patients in Canada to reduce emergency department utilization. Binding A; Ward R; Phua C; Naessens V; O'Brien T; Bhatia S; Baranek H; Marani H; Mukerji G CJEM; 2019 Jan; 21(1):55-62. PubMed ID: 29039292 [TBL] [Abstract][Full Text] [Related]
12. Impact of early analgesia on hospitalization outcomes for sickle cell pain crisis. Payne J; Aban I; Hilliard LM; Madison J; Bemrich-Stolz C; Howard TH; Brandow A; Waite E; Lebensburger JD Pediatr Blood Cancer; 2018 Dec; 65(12):e27420. PubMed ID: 30151977 [TBL] [Abstract][Full Text] [Related]
13. Low-Dose Ketamine Infusion for Adjunct Management during Vaso-occlusive Episodes in Adults with Sickle Cell Disease: A Case Series. Palm N; Floroff C; Hassig TB; Boylan A; Kanter J J Pain Palliat Care Pharmacother; 2018 Mar; 32(1):20-26. PubMed ID: 29791238 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of Vaso-occlusive Crisis Management With Patient-Controlled Analgesia in Children With Sickle Cell Disease Requiring Hospitalization. Arbitre C; Pastore Y; Bailey B; Kleiber N; Robitaille N; Villeneuve E; Viau A; Bergeron MJ; Trottier ED J Pediatr Pharmacol Ther; 2021; 26(6):615-623. PubMed ID: 34421412 [TBL] [Abstract][Full Text] [Related]
15. High inpatient dose of opioid at discharge compared to home dose predicts readmission risk in sickle cell disease. Han J; Saraf SL; Gowhari M; Jain S; Molokie RE; Gordeuk VR Am J Hematol; 2019 Jan; 94(1):E5-E7. PubMed ID: 30299555 [No Abstract] [Full Text] [Related]
16. Derivation and preliminary validation of a risk score to predict 30-day ED revisits for sickle cell pain. Glassberg J; Simon J; Patel N; Jeong JM; McNamee JJ; Yu G Am J Emerg Med; 2015 Oct; 33(10):1396-401. PubMed ID: 26283616 [TBL] [Abstract][Full Text] [Related]